Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine and remifentanil for hemodynamic changes after intubation in children
IRCT20160301026866N7Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and remifentanil in Cardiovascular collapse and respiratory complication, sponsored by Isfahan University of Medical Sciences. Primary endpoint: Hemodynamic changes after intubation. Started Sep 2018; status: completed.
02
Drugs
dexmedetomidineremifentanil
03
Conditions
Cardiovascular collapserespiratory complication
Beyond the preview
Go deeper on IRCT20160301026866N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160301026866N7.